IRBNet

ACRES seeks to build global clinical research system operating with shared procedures and policies

Monday, March 28, 2011

A growing concern in the pharmaceutical industry has been that its approach to clinical trials, particularly on a global scale, no longer works. The rising cost of clinical research, difficulties in recruiting patients, tensions about ethical oversight in developing countries, dry pipelines and concerns about drug safety and efficacy have caused many forward-thinking industry leaders to explore new models for global drug development.

[Read More]